The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo.
about
Analysis of cell kinetics using a cell division marker: mathematical modeling of experimental dataInhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro.Failure of CD4 T-cells to respond to liver-derived antigen and to provide help to CD8 T-cells.New tools to trace populations of inflammatory cells in the CNS.Development of new strategies to prevent type 1 diabetes: the role of animal models.Helper T cells, dendritic cells and CTL Immunity.Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple SclerosisIL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells.Co-administration of CD40 agonistic antibody and antigen fails to overcome the induction of oral tolerance
P2860
Q30789439-3B3A3CBD-F116-402F-B38E-2C33BF9FC377Q33722456-02F2DD1E-0394-4853-BA5A-8D2055D7DB1DQ33968107-2E1DF12F-5652-449D-966D-B72EEACBE4D8Q34398610-F11FE52E-6054-46D0-8C7C-468A8AB1F913Q35622028-397A96DA-4539-482C-83C0-8ED7E5449AE3Q35675903-73F8422E-AEF3-4392-A919-20688D1E3226Q35794340-479E249E-348A-4E1B-B10A-98F2EECC98EDQ39741074-0189563A-8D66-47EB-AF9D-1446552D774CQ47631638-1348790E-6CB3-4B92-B481-765AEE88E049Q56903617-6368AFE8-7CFD-43F8-BD88-1D68A41513A0
P2860
The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The use of carboxyfluorescein ...... antigen presentation in vivo.
@ast
The use of carboxyfluorescein ...... antigen presentation in vivo.
@en
type
label
The use of carboxyfluorescein ...... antigen presentation in vivo.
@ast
The use of carboxyfluorescein ...... antigen presentation in vivo.
@en
prefLabel
The use of carboxyfluorescein ...... antigen presentation in vivo.
@ast
The use of carboxyfluorescein ...... antigen presentation in vivo.
@en
P2093
P2860
P1476
The use of carboxyfluorescein ...... antigen presentation in vivo.
@en
P2093
Carbone FR
P2860
P304
P356
10.1046/J.1440-1711.1999.00868.X
P577
1999-12-01T00:00:00Z